the aid library

LIST OPTIONS

Filter

5057

Sort by:

Direction:

Download (109)

View PDF (154)

Perceptions and experiences of nurses about the mobile clinic work environment

Stemmet, C.L. (2016) C1

Thesis presented in partial fulfilment of the requirements for the degree of Master of Nursing Science in the Faculty of Health Sciences at Stellenbosch University. The mobile clinic health care services fulfil an essential role in delivering primary health care to the dwellers in the rural commun... more

Download (125)

View PDF (544)

Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Abras A., Ballart C., Fernández-Arévalo A., et al. Clinical Microbiology Reviews (2022) CC

Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where the disease is endemic, congenital CD (cCD... more

Download (111)

View PDF (142)

COVID-19: Strategic preparedness and response plan for WHO African Region 1 February 2021-31 January 2022 (Update of 16 April 2021)

World Health Organization WHO, Regional Office of Africa; UNICEF (2021) C_WHO

The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-national levels. The 2021 SPRP: 1. Builds upon the lessons learnt from the implementation of the 2020 SPRP and outl... more

Download (106)

View PDF (124)

Covid-19 pandemic impact on maternal and child health services access in Nampula, Mozambique: a mixed methods research

das Neves Martins Pires P.H. , Macaringue C. , Abdirazak A. et al. BMC Health Services (2021) CC

The Covid-19 pandemic has so far infected more than 30 million people in the world, having major impact on global health with collateral damage. In Mozambique, a public state of emergency was declared at the end of March 2020. This has limited people's movements and reduced public services, leading ...to a decrease in the number of people accessing health care facilities. An implementation research project, The Alert Community for a Prepared Hospital, has been promoting access to maternal and child health care, in Natikiri, Nampula, for the last four years. Nampula has the second highest incidence of Covid-19. The purpose of this study is to assess the impact of Covid-19 pandemic Government restrictions on access to maternal and child healthcare services. We compared health centres in Nampula city with healthcare centres in our research catchment area. We wanted to see if our previous research interventions have led to a more resilient response from the community. METHODS: Mixed-methods research, descriptive, cross-sectional, retrospective, using a review of patient visit documentation. We compared maternal and child health care unit statistical indicators from March-May 2019 to the same time-period in 2020. We tested for significant changes in access to maternal and child health services, using KrushKall Wallis, One-way Anova and mean and standard deviation tests. We compared interviews with health professionals, traditional birth attendants and patients in the two areas. We gathered data from a comparable city health centre and the main city referral hospital. The Marrere health centre and Marrere General Hospital were the two Alert Community for a Prepared Hospital intervention sites. RESULTS: Comparing 2019 quantitative maternal health services access indicators with those from 2020, showed decreases in most important indicators: family planning visits and elective C-sections dropped 28%; first antenatal visit occurring in the first trimester dropped 26%; hospital deliveries dropped a statistically significant 4% (p = 0.046), while home deliveries rose 74%; children vaccinated down 20%. CONCLUSION: Our results demonstrated the negative collateral effects of Covid-19 pandemic Government restrictions, on access to maternal and child healthcare services, and highlighted the need to improve the health information system in Mozambique. more

Download (247)

View PDF (332)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (157)

View PDF (206)

Climate change and communicable diseases: a manual for health workers

World Health Organization. Regional Office for Europe (2011) C_WHO

There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change. ... more

Download (68)

View PDF (517)

Peru − Progress in health and sciences in 200 years of independence

Carrillo-Larco; R.M.; Guzman-Vilca, W. C.; Leon-Velarde, F.; et al. The Lancet Regional Health - Americas (2021) CC

Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and... more

Download (1490)

View PDF (1098)

Nurses & Midwives: The Frontline Against HIV/AIDS

ICAP Nurse Capacity Initiative ICAP (2013) CC

HOW ICAP IS BUILDING NURSING AND MIDWIFERY CAPACITY AND STRENGTHENING HEALTH SYSTEMS

Download (882)

View PDF (1675)

HIV/AIDS/STI Surveillance Report

Ministry of Health, Tanzania (2014) C1

Please download the latest report from the official website: http://www.nacp.go.tz/site/publications/epidemiology-and-research-coordination

Download (461)

View PDF (446)

WHO policy on collaborative TB/HIV activities (Guidelines) (Chinese Version)

World Health Organization 世界卫生组织 (2012) C_WHO

Guidelines for national programmes and other stakeholders 世界卫生组织结核菌/艾滋病病毒双重感染防治政策指南 ——适用于国家规划和利益攸关方

Download (397)

View PDF (547)

HIV/AIDS in Ethiopia

MEASURE DHS (2013) C2

Data from the 2011 Ethiopia Demographic and Health Survey

Download (110)

View PDF (161)

Children affected by HIV/AIDS in South Africa

R. Smart; HIVAIDS Consultant Save the Children (UK) South Africa Programme; The Department of Social Development (2003) C2

A Rapid Appraisal of Priorities, Policies and Practices

Download (216)

View PDF (304)

WHO policy on collaborative TB/HIV activities (Annexes)

World Health Organization (2012) C_WHO

Guidelines for national programmes and other stakeholders Annexes for webposting and CD-Rom distribution with the policy guidelines

Download (280)

View PDF (501)

WHO policy on collaborative TB/HIV activities (Guidelines)

World Health Organization WHO (2012) C_WHO

Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/

Download (127)

View PDF (145)

Two Decades of HIV/AIDS in Tajikistan: Reversing the Tide or the Coming of Age Paradigm?

A. Latypov Central Asia-Caucasus Institute; Silk Road Studies Program; Research Gate (2008) C2

China and Eurasia Forum Quarterly, Volume 6, No. 3 (2008) p. 101-128 © Central Asia-Caucasus Institute & Silk Road Studies Program ISSN: 1653-4212

Download (268)

View PDF (330)

Isoniazid Preventive Therapy for the Prevention of Tuberculosis in People Living with HIV/AIDS

L. Hart fhi 360 (2011) C2

Moving avidence into action This document is part of a series of briefs for health program managers interested in implementing evidence-based programs. With a special emphasis on underutilized interventions, they present evidence on programs that work and provide guidance and resources for replicat... more